Leo Cancer Care and GE HealthCare Advance Radiation Therapy
MIDDLETON, WISCONSIN, Aug 28, 2026 Leo Cancer Care has announced a commercial collaboration with GE HealthCare to explore the...
Dialysis
Advertisement
AES Cleanroom Technology Gains FM 4882 Approval
MONTGOMERYVILLE, PENNSYLVANIA, Aug 27, 2026 AES Cleanroom Technology announced that its modular cleanroom wall and ceiling panel system has...
Fresenius Medical Care Reports Lower Mortality With HDF
BAD HOMBURG, GERMANY, Aug 27, 2026 Fresenius Medical Care has announced the publication of a large multinational real-world evidence...
Alebund Pharmaceuticals Gains China NMPA NDA Acceptance
SHANGHAI, August 7, 2026 Alebund Pharmaceuticals announced that China’s National Medical Products Administration (NMPA) has formally accepted for review...
Xeltis Surpasses 50% Enrollment in aXess US Trial
EINDHOVEN, The Netherlands, July 2, 2026 Xeltis announced that it has surpassed 50% patient enrollment in its U.S. pivotal...
Advertisements
Alebund Pharma Completes Phase 3 AP301 Enrollment
SHANGHAI, China – May 6, 2026 Alebund Pharmaceuticals (Jiangsu) Limited has announced the completion of patient enrollment in its...
Unicycive Therapeutics to Resubmit OLC NDA After FDA Type A Meeting
Los Altos, California, October 28, 2025 — Unicycive Therapeutics, Inc., a clinical-stage biopharmaceutical company developing treatments for kidney disease,...
Phraxis Marks First Commercial Use of EndoForce Anastomotic Connector
MINNEAPOLIS, August 29, 2025 — Phraxis announced the successful completion of the first-ever commercial case using its EndoForce Anastomotic...
Advertisement
